The effect of age and genotype on lung function in children with cystic fibrosis
| Autor: | N.Yu. Kashirskaya, Elena Kondratyeva, A.Yu. Voronkova, M. Starinova, O. I. Simonova, V. V. Shadrina, D. Sergienko, S. Yu. Semykin |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Pulmonary and Respiratory Medicine
Spirometry medicine.medical_specialty medicine.diagnostic_test business.industry Significant difference medicine.disease Medical care Cystic fibrosis 03 medical and health sciences 0302 clinical medicine 030228 respiratory system Age groups Internal medicine Genotype Medicine Russian federation 030212 general & internal medicine business Lung function |
| Zdroj: | PULMONOLOGIYA. 31:159-166 |
| ISSN: | 2541-9617 0869-0189 |
| Popis: | Identifying the initial manifestations of pulmonary functional disorders associated with cystic fibrosis (CF) is essential for timely correction of the therapy and improvement of the prognosis.The aim of the study was to identify the age periods with the highest risk of a decrease in lung function in children with different CF genotypes.Methods. Lung function (LF) was analyzed using spirometry results in CF patients aged 6 to 18 years from the Registry of patients with cystic fibrosis in the Russian Federation 2018.Results. The forced expiratory volume in one second (FEV1) was statistically significantly lower in children aged 6 – 10 years with “severe” genotypes than in the children with “mild” genotypes. The lung function was reduced at 11 – 14 years of age in both “severe» and “mild” genotypes without any statistically significant difference. In general, the trend of a decrease in lung function in “severe” genotypes persists in the adolescent period from 15 to 18 years. The lung function is better in adolescents aged 15 – 18 with the “mild” variants of genotypes compared to the patients aged 11 – 14 years.Conclusion. The “severe” variants of CFTR negatively affect LF of CF patients in all age groups. The LF values in patients with “mild” genotypes at the age of 15 – 18 years were higher than in children aged 11 – 14 years with the same genotypes. There is a need for improved programs of medical care for adolescents with CF. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|